Pacific Northwest team unveiled the largest virus proteome to date
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
On Sept. 14, 2004, Pacific Northwest National Laboratory (PNNL) announced it had received a $10.3 million biodefense contract…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
On May 25, 2004, researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate…
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
On Oct. 21, 2003, scientists at Oregon Health Sciences University’s (OHSU) Casey Eye Institute announced they had found…
On Sept. 22, 2003 the Oregon Investment Fund was created with HB 3613 passage in the Oregon State…
On Aug. 17, 2003, Oregon Health & Science University (OHSU) announced the final results of a smallpox vaccine…
On Jul. 10, 2003, the University Fertility Consultants at Oregon Health & Science University (OHSU) announced they had…
On Jul. 2, 2003, Invitrogen bought Molecular Probes for $325 million in cash. The company became part of…
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
On Feb. 1, 2002, the U.S. Food and Drug Administration (FDA) approved the drug Gleevec, formerly known as…
On Nov. 7, 2001, the Oregon Health Sciences University Foundation (OHSU) announced that the Klamath Falls-based JELD-WEN Foundation…
On Jul. 1, 2001, Governor John Kitzhaber signed legislation that expanded Oregon Health & Science University’s (OHSU) mission…
On May 10, 2001, the U.S. Food and Drug Administration (FDA) approved Gleevec, the world’s first targeted cancer…
On Jan. 11, 2001, Oregon Health Sciences University (OHSU) researchers reported the production of the world’s first genetically…
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
In 2001, the Oregon Health & Science University (OHSU) Vaccine and Gene Therapy Institute and Neurological Sciences Institute…
In 2001, Oregon Health Sciences Center’s name changed to Oregon Health & Science University (OHSU) as Governor John…
On Apr. 10, 2000, the Oregon Health Science Centers (OHSU) Center for Research on Occupational and Environmental Toxicology…
In 1998, The Oregon College of Dentistry was founded in Portland.
In 1998, the Neurological Sciences Institute (NSI) joined the university as its fifth research unit. NSI researchers conduct…
In 1998, Doernbecher Children’s Hospital’s new state-of-the-art pediatric medical complex was opened. Built with private funding and bond…
In 1998, The Mark O. Hatfield Research Center was dedicated. The center houses a variety of basic and…
In 1997, planning began for Oregon Health & Science University’s (OHSU) Center for Women’s Health, and an interim…
In 1997, the Oregon Cancer Center was established with a grant from the National Cancer Institute (NCI) of…
In 1997, Oregon Health & Science University (OHSU) announced that the institute achieved National Cancer Institute (NCI) designation,…
In 1995, Oregon Health & Science University (OHSU) became a public corporation and separated from the Oregon State…
In 1995, Senator Mark Hatfield received the Albert Lasker Public Service Award “For energetic leadership and enduring advocacy…